Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · IEX Real-Time Price · USD
9.44
-0.02 (-0.21%)
At close: Mar 28, 2024, 4:00 PM
8.97
-0.47 (-4.98%)
After-hours: Mar 28, 2024, 7:20 PM EDT

Fulcrum Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019
Market Capitalization
586417379717322388
Market Cap Growth
-10.13%-47.17%123.05%-17.20%-
Enterprise Value
359191188498208291
PE Ratio
-4.29-4.29-3.45-8.87-4.54-4.32
PS Ratio
208.88148.7759.7537.4336.45-
PB Ratio
2.491.771.913.393.384.46
P/FCF Ratio
-4.56-4.56-3.83-8.94-5.85-9.63
P/OCF Ratio
-4.59-4.59-3.90-9.14-5.99-9.84
EV/Sales Ratio
128.1368.0329.7025.9923.53-
EV/EBITDA Ratio
-2.01-2.01-1.75-6.36-3.03-3.60
EV/EBIT Ratio
-1.96-1.96-1.71-6.16-2.93-3.51
EV/FCF Ratio
-2.09-2.09-1.90-6.21-3.77-7.20
Debt / Equity Ratio
0.050.050.07---
Debt / EBITDA Ratio
-0.11-0.11-0.12---
Debt / FCF Ratio
-0.12-0.12-0.14---
Quick Ratio
17.3917.3912.2111.614.368.06
Current Ratio
17.7117.7112.4111.774.478.24
Asset Turnover
0.010.010.030.100.070
Return on Equity (ROE)
-36.60%-36.60%-57.10%-47.50%-72.10%-764.90%
Return on Assets (ROA)
-33.60%-33.60%-49.40%-41.20%-55.40%-91.50%
Return on Capital (ROIC)
-44.98%-44.98%-53.00%-38.32%-75.24%-96.63%
Earnings Yield
-16.61%-23.32%-28.99%-11.27%-22.02%-23.12%
FCF Yield
-15.61%-21.92%-26.13%-11.18%-17.10%-10.39%
Buyback Yield / Dilution
-36.27%-36.27%-27.23%-39.47%-129.53%-778.76%
Total Shareholder Return
-36.27%-36.27%-27.23%-39.47%-129.53%-778.76%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).